Resmed Inc Stock Price History
RMD Stock | USD 236.19 6.54 2.85% |
Below is the normalized historical share price chart for ResMed Inc extending back to June 02, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ResMed stands at 236.19, as last reported on the 25th of February, with the highest price reaching 236.31 and the lowest price hitting 229.25 during the day.
If you're considering investing in ResMed Stock, it is important to understand the factors that can impact its price. ResMed Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.0502, which implies the firm had a -0.0502 % return per unit of risk over the last 3 months. ResMed Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ResMed's Coefficient Of Variation of (13,098), variance of 3.2, and Risk Adjusted Performance of 3.0E-4 to confirm the risk estimate we provide.
At present, ResMed's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 116.6 M, whereas Common Stock Total Equity is forecasted to decline to about 417 K. . At present, ResMed's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 24.07, whereas Price Book Value Ratio is forecasted to decline to 4.77. ResMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of June 1995 | 200 Day MA 229.0347 | 50 Day MA 238.3534 | Beta 0.701 |
ResMed |
Sharpe Ratio = -0.0502
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RMD |
Estimated Market Risk
1.84 actual daily | 16 84% of assets are more volatile |
Expected Return
-0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ResMed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ResMed by adding ResMed to a well-diversified portfolio.
Price Book 6.4207 | Enterprise Value Ebitda 19.9594 | Price Sales 6.8459 | Shares Float 145.9 M | Dividend Share 2.02 |
ResMed Stock Price History Chart
There are several ways to analyze ResMed Stock price data. The simplest method is using a basic ResMed candlestick price chart, which shows ResMed price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 30, 2025 | 257.07 |
Lowest Price | January 2, 2025 | 227.97 |
ResMed February 25, 2025 Stock Price Synopsis
Various analyses of ResMed's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ResMed Stock. It can be used to describe the percentage change in the price of ResMed from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ResMed Stock.ResMed Accumulation Distribution | 29,263 | |
ResMed Price Rate Of Daily Change | 1.03 | |
ResMed Price Daily Balance Of Power | 0.93 | |
ResMed Price Action Indicator | 6.68 |
ResMed February 25, 2025 Stock Price Analysis
ResMed Stock Price History Data
The price series of ResMed for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 29.1 with a coefficient of variation of 2.98. The price distribution for the period has arithmetic mean of 238.99. The median price for the last 90 days is 238.03. The company completed stock split (2:1) on 31st of August 2010. ResMed Inc had dividends distributed to its stock-holders on 2025-02-13.Open | High | Low | Close | Volume | ||
02/25/2025 | 229.65 | 236.31 | 229.25 | 236.19 | 979,473 | |
02/24/2025 | 231.69 | 231.82 | 228.18 | 229.65 | 1,918,777 | |
02/21/2025 | 232.31 | 233.38 | 230.34 | 231.69 | 518,460 | |
02/20/2025 | 233.01 | 234.61 | 231.62 | 232.79 | 662,270 | |
02/19/2025 | 239.43 | 240.00 | 231.48 | 234.51 | 941,926 | |
02/18/2025 | 231.10 | 232.96 | 228.87 | 230.58 | 1,000,987 | |
02/14/2025 | 241.86 | 243.48 | 232.76 | 232.98 | 1,025,932 | |
02/13/2025 | 238.90 | 239.52 | 235.77 | 239.48 | 696,363 | |
02/12/2025 | 235.84 | 236.90 | 232.95 | 236.07 | 674,124 | |
02/11/2025 | 236.25 | 238.29 | 235.64 | 236.90 | 581,387 | |
02/10/2025 | 238.44 | 240.30 | 236.44 | 238.03 | 819,684 | |
02/07/2025 | 237.23 | 238.53 | 235.10 | 236.41 | 830,563 | |
02/06/2025 | 241.47 | 242.86 | 234.57 | 236.65 | 992,644 | |
02/05/2025 | 241.57 | 245.44 | 239.92 | 242.04 | 1,000,259 | |
02/04/2025 | 239.56 | 244.72 | 238.33 | 239.92 | 1,401,702 | |
02/03/2025 | 241.46 | 243.74 | 234.47 | 240.01 | 1,978,818 | |
01/31/2025 | 257.42 | 259.37 | 234.47 | 235.65 | 2,599,352 | |
01/30/2025 | 254.77 | 262.46 | 253.53 | 257.07 | 1,832,880 | |
01/29/2025 | 249.11 | 252.93 | 247.66 | 252.29 | 932,194 | |
01/28/2025 | 251.91 | 252.83 | 249.07 | 249.38 | 921,475 | |
01/27/2025 | 248.90 | 258.12 | 248.73 | 254.13 | 1,253,809 | |
01/24/2025 | 247.63 | 250.20 | 242.69 | 249.95 | 778,470 | |
01/23/2025 | 246.08 | 248.56 | 244.12 | 248.32 | 643,904 | |
01/22/2025 | 245.52 | 248.31 | 244.37 | 246.78 | 762,853 | |
01/21/2025 | 243.99 | 248.75 | 243.33 | 247.23 | 1,047,883 | |
01/17/2025 | 237.46 | 239.83 | 235.35 | 239.24 | 776,858 | |
01/16/2025 | 234.47 | 240.06 | 232.56 | 236.60 | 797,110 | |
01/15/2025 | 230.17 | 233.41 | 228.57 | 232.86 | 1,147,621 | |
01/14/2025 | 231.29 | 231.60 | 227.16 | 228.32 | 692,792 | |
01/13/2025 | 231.00 | 231.03 | 226.75 | 229.74 | 580,194 | |
01/10/2025 | 231.75 | 234.92 | 229.34 | 233.30 | 1,043,431 | |
01/08/2025 | 233.52 | 236.67 | 231.99 | 235.64 | 878,752 | |
01/07/2025 | 235.48 | 239.20 | 234.37 | 235.87 | 675,161 | |
01/06/2025 | 231.32 | 236.72 | 230.48 | 234.56 | 793,784 | |
01/03/2025 | 228.05 | 231.34 | 226.44 | 231.15 | 639,425 | |
01/02/2025 | 230.47 | 230.47 | 226.15 | 227.97 | 558,305 | |
12/31/2024 | 230.17 | 231.58 | 227.76 | 228.18 | 522,844 | |
12/30/2024 | 231.66 | 232.00 | 227.60 | 228.99 | 504,397 | |
12/27/2024 | 233.22 | 233.86 | 230.57 | 232.66 | 390,886 | |
12/26/2024 | 230.44 | 234.22 | 230.44 | 233.36 | 390,213 | |
12/24/2024 | 231.29 | 232.06 | 229.07 | 232.06 | 227,615 | |
12/23/2024 | 229.69 | 231.48 | 224.01 | 230.65 | 1,151,442 | |
12/20/2024 | 230.48 | 238.07 | 230.48 | 236.74 | 3,057,163 | |
12/19/2024 | 231.15 | 234.97 | 229.49 | 231.06 | 596,843 | |
12/18/2024 | 238.50 | 239.64 | 229.42 | 229.69 | 871,441 | |
12/17/2024 | 241.46 | 244.64 | 240.86 | 242.08 | 739,288 | |
12/16/2024 | 238.13 | 241.30 | 230.48 | 240.48 | 829,780 | |
12/13/2024 | 240.74 | 240.96 | 236.42 | 237.99 | 580,589 | |
12/12/2024 | 242.62 | 247.37 | 240.91 | 241.97 | 922,342 | |
12/11/2024 | 244.64 | 245.46 | 241.52 | 245.23 | 514,234 | |
12/10/2024 | 244.61 | 245.95 | 241.46 | 244.67 | 505,873 | |
12/09/2024 | 243.68 | 247.20 | 241.63 | 244.21 | 583,582 | |
12/06/2024 | 239.94 | 244.58 | 238.87 | 240.87 | 462,436 | |
12/05/2024 | 242.51 | 244.56 | 238.19 | 238.87 | 642,392 | |
12/04/2024 | 245.10 | 246.08 | 242.81 | 245.29 | 884,183 | |
12/03/2024 | 243.79 | 248.91 | 243.79 | 246.36 | 664,996 | |
12/02/2024 | 248.35 | 248.35 | 242.83 | 244.37 | 575,940 | |
11/29/2024 | 247.91 | 251.79 | 247.19 | 248.46 | 351,327 | |
11/27/2024 | 250.42 | 250.80 | 247.35 | 248.77 | 654,486 | |
11/26/2024 | 249.15 | 250.64 | 246.72 | 249.43 | 676,207 | |
11/25/2024 | 243.98 | 249.21 | 243.05 | 249.00 | 1,708,448 |
About ResMed Stock history
ResMed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ResMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ResMed Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ResMed stock prices may prove useful in developing a viable investing in ResMed
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 169.7 M | 147.7 M | |
Net Income Applicable To Common Shares | 1 B | 1.1 B |
ResMed Quarterly Net Working Capital |
|
ResMed Stock Technical Analysis
ResMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
ResMed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ResMed's price direction in advance. Along with the technical and fundamental analysis of ResMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ResMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 3.0E-4 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.01) | |||
Treynor Ratio | (0.04) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |